FDA Inspection 1109412 — Ondrej Jerabek
The FDA completed an inspection of Ondrej Jerabek on October 18, 2019 in Pribram Viii. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 18, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pribram Viii (Czech Republic)
Additional Details
Clinical Investigator (CI)